K -sample omnibus non-proportional hazards tests based on right-censored data

Abstract

This work presents novel and powerful tests for comparing non-proportional hazard functions, based on sample–space partitions. Right censoring introduces two major difficulties, which make the existing sample–space partition tests for uncensored data non-applicable: (i) the actual event times of censored observations are unknown and (ii) the standard permutation procedure is invalid in case the censoring distributions of the groups are unequal. We overcome these two obstacles, introduce invariant tests, and prove their consistency. Extensive simulations reveal that under non-proportional alternatives, the proposed tests are often of higher power compared with existing popular tests for non-proportional hazards. Efficient implementation of our tests is available in the R package KONPsurv, which can be freely downloaded from CRAN.

Keywords

Combined test consistent test crossing hazards non-parametric test permutation test right censoring sample–space partition versatile test

Get full access to this article

View all access options for this article.

References

Yang

Prentice

RL.

Improved logrank-type tests for survival data using adaptive weights.

Biometrics 2010; 66: 30–38.

Peto

Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972; 185–207.

Pepe

Fleming

TR.

Weighted Kaplan–Meier statistics: a class of distance tests for censored survival data. Biometrics 1989; 497–507.

Pepe

Fleming

TR.

Weighted Kaplan–Meier statistics: large sample and optimality considerations. J R Stat Soc B 1991; 341–352.

Yang

Prentice

RL.

Semiparametric analysis of short-term and long-term hazard ratios with two-sample survival data. Biometrika 2005; 92: 1–17.

Darling

DA.

The Kolmogorov–Smirnov, Cramer–von Mises tests. Ann Math Stat 1957; 28: 823–838.

Pettitt

AN.

A two-sample Anderson–Darling rank statistic. Biometrika 1976; 63: 161–168.

Scholz

Stephens

MA.

k-sample Anderson–Darling tests. J Am Stat Assoc 1987; 82: 918–924.

Thas

Ottoy

JP.

An extension of the Anderson–Darling k-sample test to arbitrary sample space partition sizes. J Stat Comput Simul 2004; 74: 651–665.

10.

Heller

Gorfine

A consistent multivariate test of association based on ranks of distances. Biometrika 2013; 100: 503–510.

11.

Heller

Kaufman

, et al. Consistent distribution-free K-sample and independence tests for univariate random variables. J Mach Learn Res 2016; 17: 978–1031.

12.

Liu

Xie

Cauchy combination test: a powerful test with analytic p-value calculation under arbitrary dependency structures. J Am Stat Assoc 2019; 1–18.

13.

Seung-Hwan

On the versatility of the combination of the weighted log-rank statistics. Comput Stat Data Anal 2007; 51: 6557–6564.

14.

Lin

Roychoudhury

, et al. Alternative analysis methods for time to event endpoints under non-proportional hazards: a comparative analysis. Statistics in Biopharmaceutical Research 2020; pp.1–19.

15.

Wang

Lagakos

Gray

RJ.

Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

Biostatistics 2010; 11: 676–692.

16.

Uno

Tian

Claggett

, et al.

A versatile test for equality of two survival functions based on weighted differences of Kaplan–Meier curves.

Stat Med 2015; 34: 3680–3695.

17.

Yang

Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.

Stat Med 2019; 38: 601–612.

18.

Lin

Wei

Ying

Checking the cox model with cumulative sums of martingale-based residuals. Biometrika 1993; 80: 557–572.

19.

Schlesinger

Gorfine

Konp tests: powerful k-sample tests for right-censored data. R package version 1.0.1. 2019.

20.

Schein

and Gastrointestinal Tumor Study Group. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Cancer 1982; 49: 1771–1777.

21.

Powles

Durán

van der Heijden

, et al.

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

Lancet 2018; 391: 748–757.

22.

Roychoudhury

Anderson

, et al. Robust design and analysis of clinical trials with non-proportional hazards: a straw man guidance from a cross-pharma working group. arXiv preprint 2019; DOI: arXiv:1908.07112.

23.

Guyot

Ades

Ouwens

, et al.

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.

BMC Med Res Methodol 2012; 12(1): 9.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.43 MB